News
🇺🇸 FDA Page 58Latest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 685–696 of 807 articles
Mabwell's MAIWEIJIAN Denosumab Gets NMPA Acceptance for Expanded Cancer Bone Treatment
ThinkTrends AI Platform Deployed by Federal Health Agency for Nationwide Adverse Event Monitoring System
Fullscript Journeys Launches Digital Health Platform for 125,000 Healthcare Providers
Nexalin Technology Advances FDA Strategy for Alzheimer's Treatment Following U.S. and China Leadership Meetings
FDA Warning Letters: Understanding Pharmaceutical Compliance Actions and Their Impact on Drug Safety
GSK's Depemokimab Receives European and Chinese Approvals, Expanding Global Access to Ultra-Long-Acting Biologic
Elion Therapeutics Launches Phase 2 Trial for Turletricin (EL219) in Invasive Mold Infections
Glaukos Receives Permanent J-Code J2789 for Epioxa™ Ophthalmic Treatment, Effective July 2026
Nkarta Receives FDA Approval for Outpatient NKX019 Dosing in Autoimmune Disease Treatment
Dogwood Therapeutics SP16 Gets FDA IND Approval for Chemotherapy-Induced Pain Treatment
PDS Biotech's PDS01ADC Shows 78% Response Rate in Metastatic Colorectal Cancer Phase 2 Trial
Neffy Epinephrine Nasal Spray Approved in Canada as First Needle-Free Anaphylaxis Treatment by ARS Pharmaceuticals